-
Taxonomy & unit
-
ifrs-full: USD
-
Summary
-
Xtl Biopharmaceuticals Ltd annual/quarterly Research And Development Expense history and growth rate from Q2 2020 to Q2 2022.
- Xtl Biopharmaceuticals Ltd Research And Development Expense for the quarter ending June 30, 2022 was $15K, a 150% increase year-over-year.
- Xtl Biopharmaceuticals Ltd annual Research And Development Expense for 2022 was $30K, unchanged from 2021.
- Xtl Biopharmaceuticals Ltd annual Research And Development Expense for 2021 was $30K, a 21.1% decline from 2020.
- Xtl Biopharmaceuticals Ltd annual Research And Development Expense for 2020 was $38K, a 8.57% increase from 2019.
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Growth (%)